Abstract
Cardiovascular disease (CVD) is a major underlying cause of death, with high economic burden in most countries, including the United States. Lifestyle modifications and the use of antiplatelet therapy, such as aspirin, can contribute significantly to secondary prevention of CVD in adults. This study examined the prevalence and associated factors of aspirin use for the secondary prevention of angina pectoris, myocardial infarction (MI), and cerebrovascular disease (stroke) in a sample of American adults. The 2015 Behavioral Risk Factor Surveillance System (BRFSS) dataset was analyzed for this cross-sectional study. Almost 16% of the study population (N = 441,456) had angina, MI, or stroke. Weighted percentages of respondents with angina, MI, and stroke were 4%, 4.3%, and 3%, respectively. Overall, weighted prevalence of daily (or every other day) aspirin use was about 65%, 71%, and 57% among respondents with angina, MI, and stroke, respectively. Factors that were significantly associated with aspirin use included male sex, more than high school education, high blood pressure, diabetes, and less than excellent general health. There were existing differences among individuals with CVD based on diagnosis, demographic and socioecono...Continue Reading
References
Nov 1, 2003·Thrombosis Research·J R Vane, R M Botting
Mar 18, 2004·Cerebrovascular Diseases·Diederik W J DippelPeter J Koudstaal
Jun 9, 2005·Annals of Internal Medicine·Cynthia Mulrow, Michael Pignone
Dec 2, 2005·The New England Journal of Medicine·Carlo PatronoColin Baigent
Jan 19, 2006·JAMA : the Journal of the American Medical Association·Jeffrey S BergerDavid L Brown
Mar 14, 2007·Journal of General Internal Medicine·Alexander R OpotowskyChristopher P Cannon
Sep 21, 2007·Atherosclerosis·Ian GrahamUNKNOWN ESC Committee for Practice Guidelines
Feb 16, 2011·British Journal of Clinical Pharmacology·Timothy D WarnerCarl Whatling
Apr 5, 2011·The Canadian Journal of Cardiology·Alan D BellJean-François Tanguay
Feb 28, 2014·Clinical Medicine & Research·Sunitha V IttamanShereif H Rezkalla
Feb 12, 2015·The American Journal of Cardiology·Jing FangFleetwood Loustalot
Dec 25, 2015·Journal of the American Heart Association·Russell V LuepkerAlan T Hirsch
May 26, 2016·European Heart Journal·Massimo F PiepoliUNKNOWN ESC Scientific Document Group
Aug 23, 2016·Texas Heart Institute Journal·Robert W Godley, Eduardo Hernandez-Vila
Nov 16, 2016·International Journal of Environmental Research and Public Health·Benjamin E AnsaSelina A Smith
Jan 11, 2017·Preventive Medicine Reports·Mark Stuntz, Brent Bernstein
Mar 14, 2017·JRSM Cardiovascular Disease·Jack StewartPeter Wilkinson
Sep 8, 2017·Preventing Chronic Disease·Vincent L MendyLei Zhang
Aug 31, 2018·Lancet·Davide Capodanno, Dominick J Angiolillo
Citations
Jun 24, 2020·Postgraduate Medicine·Morgan Spencer GoldMoshe Ben-Shoshan
Apr 2, 2021·Journal of Theoretical Biology·Muhammad Suleman AwanAfrose Liaquat
Jun 1, 2021·Human Genetics·Luis M García-MarínMiguel E Rentería
Jun 3, 2021·Healthcare·Benjamin E AnsaJ Aaron Johnson
Feb 23, 2020·Journal of Voice : Official Journal of the Voice Foundation·Daniel EichornRobert T Sataloff
Oct 28, 2021·Stroke; a Journal of Cerebral Circulation·Jay B LuskYing Xian